BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2722176)

  • 1. Primary mucosal malignant melanoma: an immunohistochemical study of 12 cases with comparison to cutaneous and metastatic melanomas.
    Fitzgibbons PL; Chaurushiya PS; Nichols PW; Chandrasoma PT; Martin SE
    Hum Pathol; 1989 Mar; 20(3):269-72. PubMed ID: 2722176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma cell heterogeneity. A study of two monoclonal antibodies compared with S-100 protein in paraffin sections.
    Duray PH; Palazzo J; Gown AM; Ohuchi N
    Cancer; 1988 Jun; 61(12):2460-8. PubMed ID: 3365669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of malignant melanoma by monoclonal antibody HMB-45. An immunohistochemical study of 200 paraffin-embedded cutaneous tumors.
    Wick MR; Swanson PE; Rocamora A
    J Cutan Pathol; 1988 Aug; 15(4):201-7. PubMed ID: 3053811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial markers in malignant melanoma. A study of primary lesions and their metastases.
    Ben-Izhak O; Stark P; Levy R; Bergman R; Lichtig C
    Am J Dermatopathol; 1994 Jun; 16(3):241-6. PubMed ID: 7524376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMB-45 detection in adenocarcinomas.
    Hancock C; Allen BC; Herrera GA
    Arch Pathol Lab Med; 1991 Sep; 115(9):886-90. PubMed ID: 1718237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of HMB-45 monoclonal antibody and S-100 protein in the immunohistochemical diagnosis of melanoma.
    Ordóñez NG; Ji XL; Hickey RC
    Am J Clin Pathol; 1988 Oct; 90(4):385-90. PubMed ID: 2459952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of cutaneous malignant melanoma: comparison of S-100 protein, HMB-45 monoclonal antibody and NKI/C3 monoclonal antibody.
    Fernando SS; Johnson S; Bäte J
    Pathology; 1994 Jan; 26(1):16-9. PubMed ID: 8165017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100 immunophenotypes of uveal melanomas.
    Kan-Mitchell J; Rao N; Albert DM; Van Eldik LJ; Taylor CR
    Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1492-6. PubMed ID: 1696942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melan A and S100 protein immunohistochemistry in feline melanomas: 48 cases.
    Ramos-Vara JA; Miller MA; Johnson GC; Turnquist SE; Kreeger JM; Watson GL
    Vet Pathol; 2002 Jan; 39(1):127-32. PubMed ID: 12102204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
    Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
    Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
    Pluot M; Joundi A; Grosshans E
    Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma.
    Orchard GE
    Histochem J; 2000 Aug; 32(8):475-81. PubMed ID: 11095072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100 protein and HMB-45.
    Heegaard S; Jensen OA; Prause JU
    Melanoma Res; 2000 Aug; 10(4):350-4. PubMed ID: 10985669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of melanocytic neoplasms: application of a pan-melanoma antibody cocktail.
    Orchard G
    Br J Biomed Sci; 2002; 59(4):196-202. PubMed ID: 12572952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marginal and joint distributions of S100, HMB-45, and Melan-A across a large series of cutaneous melanomas.
    Viray H; Bradley WR; Schalper KA; Rimm DL; Gould Rothberg BE
    Arch Pathol Lab Med; 2013 Aug; 137(8):1063-73. PubMed ID: 23899062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of S-100 immunostaining as a diagnostic tool in human malignant melanomas. A comparative study using S-100 and neuron-specific enolase antibodies.
    Springall DR; Gu J; Cocchia D; Michetti F; Levene A; Levene MM; Marangos PJ; Bloom SR; Polak JM
    Virchows Arch A Pathol Anat Histopathol; 1983; 400(3):331-43. PubMed ID: 6412442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ca(2+)-binding proteins S100A6 and S100B in primary cutaneous melanoma.
    Böni R; Heizmann CW; Doguoglu A; Ilg EC; Schäfer BW; Dummer R; Burg G
    J Cutan Pathol; 1997 Feb; 24(2):76-80. PubMed ID: 9162739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical study of malignant melanoma.
    Hirano T
    Acta Pathol Jpn; 1986 May; 36(5):733-43. PubMed ID: 3526811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
    Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
    Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants.
    Blessing K; Sanders DS; Grant JJ
    Histopathology; 1998 Feb; 32(2):139-46. PubMed ID: 9543670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.